Abstract:Since the discovery of Stimulator of Interferon Genes (STING) as an important pivot for cytosolic DNA sensation and interferon (IFN) induction, intensive efforts have been endeavored to clarify the molecular mechanism of its activation, its physiological function as a ubiquitously expressed protein, and to explore its potential as a therapeutic target in a wide range of immune-related diseases. With its orthodox ligand 2'3'-cyclic GMP–AMP (2'3'-cGAMP) and the upstream sensor 2'3'-cGAMP synthase (cGAS) to be found, STING acquires its central functionality in the best-studied signaling cascade, namely the cGAS–STING–IFN pathway. However, recently updated research through structural research, genetic screening, and biochemical assay greatly extends the current knowledge of STING biology. A second ligand pocket was recently discovered in the transmembrane domain for a synthetic agonist. On its downstream outputs, accumulating studies sketch primordial and multifaceted roles of STING beyond its cytokine-inducing function, such as autophagy, cell death, metabolic modulation, endoplasmic reticulum (ER) stress, and RNA virus restriction. Furthermore, with the expansion of the STING interactome, the details of STING trafficking also get clearer. After retrospecting the brief history of viral interference and the milestone events since the discovery of STING, we present a vivid panorama of STING biology taking into account the details of the biochemical assay and structural information, especially its versatile outputs and functions beyond IFN induction. We also summarize the roles of STING in the pathogenesis of various diseases and highlight the development of small-molecular compounds targeting STING for disease treatment in combination with the latest research. Finally, we discuss the open questions imperative to answer.

Post-Translational Modifications of STING: A Potential Therapeutic Target

Post-Translational Modifications of cGAS-STING: A Critical Switch for Immune Regulation

IUPHAR ECR review: The cGAS-STING pathway: Novel functions beyond innate immune and emerging therapeutic opportunities

The Cgas-Sting Pathway: Post-translational Modifications and Functional Implications in Diseases

Advances in the Prerequisite and Consequence of STING Downstream Signalosomes

Multifaceted functions of STING in human health and disease: from molecular mechanism to targeted strategy

Structural Insights into a Shared Mechanism of Human STING Activation by a Potent Agonist and an Autoimmune Disease-Associated Mutation.

Regulating STING in health and disease

Targeting Stimulator of Interferon Genes (STING): A Medicinal Chemistry Perspective

STING, a promising target for small molecular immune modulator: A review

Insight into the Dichotomous Regulation of STING Activation in Immunotherapy

Potential Therapeutic Value of the STING Inhibitors

When STING Meets Viruses: Sensing, Trafficking and Response

Development of small molecule inhibitors/agonists targeting STING for disease

Cgas‐sting Pathway: Post‐translational Modifications and Functions in Sterile Inflammatory Diseases

Research Advances in How the cGAS-STING Pathway Controls the Cellular Inflammatory Response

Cytosolic sensor STING in mucosal immunity: a master regulator of gut inflammation and carcinogenesis

Agonists and Inhibitors of the STING Pathway: Potential Agents for Immunotherapy

Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy

The Role of cGAS-STING Signalling in Metabolic Diseases: from Signalling Networks to Targeted Intervention

Research Progress of Stimulator of Interferon Genes